Previous 10 | Next 10 |
home / stock / alpmf / alpmf news
AstraZeneca (NYSE: AZN ) and collaboration partner Merck (NYSE: MRK ) announce positive results from a Phase 3 clinical trial, PROfound , evaluating PARP inhibitor Lynparza (olaparib) in men with metastatic castration-resistant prostate cancer (mCRPC) with a certain genetic profile called...
Editor's Note: The summary bullets for this article were chosen by Seeking Alpha Read more ...
Astellas Pharma ( OTCPK:ALPMF ) inks an agreement with Woburn, MA-based Frequency Therapeutics to co-develop and commercialize a regenerative therapeutic candidate, FX-322, for the treatment of sensorineural hearing loss. More news on: Astellas Pharma Inc., Astellas Pharma Inc., H...
Nano cap Aevi Genomic Medicine (NASDAQ: GNMX ) is up 23% after hours on the heels of its exclusive in-license agreement with Astellas Pharma ( OTCPK:ALPMF ) unit OSI Pharmaceuticals securing global development and commercialization rights to ASP7486 (formerly OSI-027). More n...
Recently in the journal Nature , an article was published characterizing the oldest known example of a fungus. The organism, termed an Ourasphaira, was approximately one billion years old and was found in what was believed to be an ancient river bed in Canada. For comparison sake, the oldes...
Seattle Genetics (NASDAQ: SGEN ) and Astellas Pharma ( OTCPK:ALPMF ) announces positive topline results from the first cohort of patients enrolling 128 patients in a phase 2 single-arm clinical trial known as EV-201. More news on: Seattle Genetics, Inc., Astellas Phar...
Quick Take Anchiano Therapeutics ( ANCN ) intends to raise $35 million in a U.S. IPO, per an amended regulatory filing . The company is developing a single biologic candidate to treat bladder and other cancers. ANCN has had promising trial results, strong existing investor support of th...
Quick Take Anchiano Therapeutics ( ANCN ) intends to raise $35 million from the sale of ADSs in a U.S IPO, per an F-1 registration statement . The company is pursuing regulatory approvals for its drug treatment pipeline for various cancers. ANCN has generated promising efficacy trial re...
News, Short Squeeze, Breakout and More Instantly...
Astellas Pharma Inc Company Name:
ALPMF Stock Symbol:
OTCMKTS Market:
Pharmaceutical stocks were initially expected to be largely immune to the COVID-19 economic downturn. Drugmakers, after all, generally produce products that are essential to daily life. However, the extreme social distancing that has become part and parcel of this unusual period has halted nume...
One of England's top healthcare watchdogs, the National Institute for Health and Care Excellence (NICE), has officially decided to stay the course and reject AstraZeneca 's (NYSE: AZN) lung cancer drug Tagrisso. A few months ago, the pharmaceutical giant argued that the drug should receive...
This past year proved profitable for investors in Incyte (NASDAQ: INCY) and Seattle Genetics (NASDAQ: SGEN) . Handily beating broad market and biotech indexes, these two drug manufacturers hit the $20 billion valuation mark and are poised to continue growing in the coming year -- unless, ...